Cibus (CBUS) EBITDA Yield: History & Chart

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T12:45:53.142Z.

Stored calculation inputs

Calculation as of: 2026-10-06T12:45:53.142Z.

Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -48,869,000
Quote market capitalization: 128,237,088
Total debt · period ending 2026-06-30: 32,742,000
Cash · period ending 2026-06-30: 20,429,000

FMP input reference: b7114033928f702054061c44125c31231f02474951b0017c983a2cfe9aac3c1c

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

CBUS EBITDA Yield Metrics

EBITDA YIELD

N/A

CBUS Competitors' EBITDA Yield

CBUS

Cibus, Inc.

Current

Market Cap

$128.24M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ENTX

Entera Bio Ltd.

vs CBUS

Market Cap

$129.14M

EBITDA Yield

N/A

TTM Avg

27.23%

3Y Avg

27.23%

5Y Avg

27.23%

HCAT

Health Catalyst, Inc.

vs CBUS

Market Cap

$130.05M

EBITDA Yield

1.35%

TTM Avg

1.37%

3Y Avg

1.37%

5Y Avg

1.37%

ENGN

enGene Holdings Inc.

vs CBUS

Market Cap

$125.27M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AIRS

AirSculpt Technologies, Inc.

vs CBUS

Market Cap

$134.74M

EBITDA Yield

0.23%

TTM Avg

0.33%

3Y Avg

3.24%

5Y Avg

2.95%

FRNM

Freenome, Inc.

vs CBUS

Market Cap

$137.29M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HURA

TuHURA Biosciences, Inc.

vs CBUS

Market Cap

$119.09M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BGM

BGM Group Ltd.

vs CBUS

Market Cap

$118.63M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMDX

Insight Molecular Diagnostics Inc.

vs CBUS

Market Cap

$118.50M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRBU

Caribou Biosciences, Inc.

vs CBUS

Market Cap

$118.02M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Cibus, Inc. (CBUS)	$128.24M	N/A	N/A	N/A	N/A
Entera Bio Ltd. (ENTX)vs ›	$129.14M	N/A	27.23%	27.23%	27.23%
Health Catalyst, Inc. (HCAT)vs ›	$130.05M	1.35%	1.37%	1.37%	1.37%
enGene Holdings Inc. (ENGN)vs ›	$125.27M	N/A	N/A	N/A	N/A
AirSculpt Technologies, Inc. (AIRS)vs ›	$134.74M	0.23%	0.33%	3.24%	2.95%
Freenome, Inc. (FRNM)vs ›	$137.29M	N/A	N/A	N/A	N/A
TuHURA Biosciences, Inc. (HURA)vs ›	$119.09M	N/A	N/A	N/A	N/A
BGM Group Ltd. (BGM)vs ›	$118.63M	N/A	N/A	N/A	N/A
Insight Molecular Diagnostics Inc. (IMDX)vs ›	$118.50M	N/A	N/A	N/A	N/A
Caribou Biosciences, Inc. (CRBU)vs ›	$118.02M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

CBUS EBITDA Yield Metrics

CBUS Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics